Elekta AB (publ) (STO:EKTA.B)
Sweden · Delayed Price · Currency is SEK 62.55
+1.95 (3.22%)
At close: May 25, 2026
Elekta AB Market Cap
Elekta AB has a market cap or net worth of 23.9 billion as of May 22, 2026. Its market cap has increased by 26.06% in one year.
Market Cap
23.90B
Enterprise Value
28.69B
Revenue
17.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
62.55
Market Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 1.51B to 23.90B, an increase of 1,486.53%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 23.15B | 6.78% |
| Dec 30, 2025 | 21.68B | -7.20% |
| Dec 30, 2024 | 23.36B | -25.72% |
| Dec 29, 2023 | 31.45B | 31.08% |
| Dec 30, 2022 | 23.99B | -45.18% |
| Dec 30, 2021 | 43.77B | 3.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Sectra AB | 53.33B |
| Vitrolife AB | 14.46B |
| Nolato AB | 13.63B |
| Xvivo Perfusion AB | 9.23B |
| MedCap AB | 8.49B |
| CellaVision AB | 2.91B |
| Devyser Diagnostics AB | 1.62B |